Cellular Vehicles

We’re excited to share our 1-minute intro video introducing the Odyssey System by Cellular Vehicles. The Odyssey System is a game-changer in the cell therapy space, designed to simplify and standardize the "last mile" delivery of cell therapy. By automating critical dose preparation steps like thawing, washing, and dosing, the Odyssey System will help biopharma and healthcare providers deliver life-saving treatments. Our innovation is set to expand access to cutting-edge therapies, allowing more patients to benefit from these amazing treatments. Check out our video below! 🌟 #CellTherapy #Automation #Biotech #MedicalDevices

🎉 We've been lucky to have Moira Crehan as our intern this summer! Moira is a talented college student with a passion for innovation in the biotech industry. 🤖 Over the summer, Moira has been working closely with the team, contributing to the development of the Odyssey System, our cutting-edge cell therapy process automation technology, as well as helping on business development efforts. Her fresh perspective and enthusiasm for the field has brought great energy to our projects. 🎒 Please connect with Moira as she returns to college for her senior year ahead of kicking off her career in biotech!

We are happy to announce a Phase I SBIR awarded to us by The National Institutes of Health/NIH SEED + National Center for Advancing Translational Sciences (NCATS) program. 🔬 This award (R43TR005112) will support the further development of our innovative Odyssey System platform towards a novel use case, namely for standardizing the preparation and delivery of cell-laden hydrogel based therapies. We believe tissue-engineered therapeutics will become a major modality used in the treatment of chronic solid-tissue based diseases, but will require significant standardization and simplification before they can be translated to patients at meaningful scale. The proposed research will enable us to adopt our technology for these emerging therapies. 🏥 Please follow us to stay updated on our progress! 🗞

We're excited to share our acceptance into this year's MedTech Innovator cohort! Our team is looking forward to benefitting from this world-class ecosystem towards commercializing our innovative solution to expand access to cell/gene therapies. Congrats to all the companies participating! Here is the full list: https://lnkd.in/gNSe9iVM #mti #medtech

Our team was thrilled by the reception and interest in our technology last week at ISCT in Vancouver! 🇨🇦 Standardizing the final mile of CGT delivery will become increasingly important as the field continues to move towards indications impacting more patients. 🏥 Please reach out if you're interested in learning more about the capabilities of the Odyssey System! 🤖 #ISCT #ISCT24

Our CTO Marcus Foley recently joined CryoChats to discuss the Odyssey System, our flexible and accessible process automation platform for the CGT field. CryoChats is a community led by Evia Bio, a company focused on the preservation of cell-based therapies through their supply chain. ❄❄❄

We’re thrilled to introduce Nikhil M. (Nico) as our new Robotics Engineer! We promise, him sharing a name with one of our founders neither hurt nor helped him get the job 😉. Nico is a Biomedical Engineer by training (BS and MS from Johns Hopkins University). During school, he was an undergraduate and graduate student researcher and developed animal-inspired robots (snakes, specifically) for search and rescue missions. 🤖 🐍 Most recently, he was a Systems Integration Engineer in J&J’s Robotics and Digital Solutions group, where he developed algorithms to make robotic and laparoscopic surgical tools “smarter”, with the goal of improving patient outcomes during surgery. 🏥 We look forward to his contributions towards the development of the Odyssey System - join us in welcoming Nico to the team! 🌟